SAM #36C24226Q0550

Sole Source Outsourced Chemotherapy Compounding Services for New York VA Medical Centers

This opportunity involves the Department of Veterans Affairs' intent to award a sole source contract for outsourced chemotherapy compounding services for several New York VA medical centers. - Sole source contract intended for Optum Infusion 308, LLC - Services include preparation and delivery of patient-specific, ready-to-administer compounded chemotherapy drugs - Must comply with VHA Directive 1108.12, USP 797, and FDA standards - Requires a one-day prescription turnaround - Includes a 15-point pharmacist check system for quality assurance - Contract period is approximately one year, from August 24, 2026 to September 30, 2027 - Services are for multiple VA medical centers in New York, including Manhattan, Brooklyn, Bronx, Hudson Valley (Castle Point), and Northport - No specific product part numbers or quantities are provided; focus is on specialized compounding services - Notice is for a sole source procurement, but other qualified pharmaceutical compounding providers could potentially compete if the requirement were opened

Description

Notice of Intent to Sole Source Additional Links:VAMC

View original listing